Center for Medicare and Medicaid Innovation
Schedules
TAFS: 075-0522 /X - Center for Medicare and Medicaid Innovation
| Line # | Split | Description | Amount | Footnotes |
|---|---|---|---|---|
| 1000 | ME | Mandatory Estimated - Unob Bal: Brought forward, Oct 1 | $6,928,712,890 | |
| 1920 | Total budgetary resources avail (disc. and mand.) | $6,928,712,890 | ||
| 6011 | Amounts Available for Future Plans | $0 | ||
| 6012 | CMMI - Administrative Support | $173,979,223 | ||
| 6020 | Building Innovations Pipeline | $28,687,364 | ||
| 6022 | Learning Systems | $18,830,782 | ||
| 6028 | Financial Alignment Initiative for Medicare-Medicaid Enrollees | $1,393,883 | ||
| 6032 | Pre-Clearance Support | $12,000,000 | ||
| 6042 | Health Care Payment Learning and Action Network (HCPLAN) | $4,670,385 | ||
| 6044 | Home Health Value Based Purchasing | $5,589,288 | ||
| 6058 | Diabetes Prevention Program Model | $3,982,311 | ||
| 6060 | Integrated Care for Kids (InCK) Model | $3,270,066 | ||
| 6061 | ACO REACH Model | $4,105,000 | ||
| 6066 | Kidney Care Choices (KCC) Model | $56,455,000 | ||
| 6074 | Enhancing Oncology Model | $9,334,751 | ||
| 6079 | GUIDE Model | $61,715,776 | ||
| 6080 | AHEAD Model | $41,951,142 | ||
| 6081 | Innovation in Behavioral Health (IBH) Model | $32,649,099 | ||
| 6082 | Cell and Gene Therapy (CGT) Access Model | $17,412,371 | ||
| 6083 | Transforming Maternal Health (TMaH) Model | $82,297,843 | ||
| 6084 | ACO Primary Care Flex (ACO PC Flex) Model | $11,186,994 | ||
| 6085 | Transforming Episode Accountability Model (TEAM) | $7,784,157 | ||
| 6086 | CMMI - Operational Support | $223,931,695 | ||
| 6087 | Increasing Organ Transplant Access (IOTA) Model | $3,914,018 | ||
| 6088 | Wasteful and Inappropriate Service Reduction (WISeR) Model | $44,999,808 | ||
| 6089 | Ambulatory Specialty Model (ASM) | $12,844,909 | ||
| 6090 | ACCESS Model | $23,900,000 | ||
| 6091 | GENEROUS Model | $9,837,904 | ||
| 6092 | MAHA ELEVATE Model | $21,894,376 | ||
| 6093 | LEAD Model | $26,494,714 | ||
| 6095 | Global Benchmark for Efficient Drug Pricing (GLOBE) Model | $11,750,000 | ||
| 6096 | Accelerating State Pediatric Innovation Readiness and Effectiveness (ASPIRE) Model | $32,400,000 | ||
| 6097 | Post Model Closeout Cost Account | $50,000 | ||
| 6098 | Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model | $4,220,000 | ||
| 6099 | Comprehensive Care for Joint Replacement Expansion (CJR-X) Model | $11,116,000 | ||
| 6170 | Apportioned in FY 2028 and Available for Future Plans | $5,924,064,031 | ||
| 6190 | Total budgetary resources available | $6,928,712,890 |
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
No footnotes available.
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.